fungemia/niðurgangur

Krækjan er vistuð á klemmuspjaldið

GreinarKlínískar rannsóknirEinkaleyfi

Veldu tegund tegund

Bls 1 frá 26 niðurstöður

Fungemia with Saccharomyces boulardii in a 1-year-old girl with protracted diarrhea.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Lung infection due to opportunistic fungus, Phialemonium obovatum, in a bone marrow transplant recipient: an emerging infection with fungemia and Crohn disease-like involvement of the gastrointestinal tract.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

We report the first case of Phialemonium obovatum fungemia with subsequent caseating granulomatas in the lung and Crohn disease-like involvement of the gastrointestinal tract in a bone marrow transplant recipient. This phaeoid fungus has been rarely described as an opportunistic infection in

Cryptococcal fungemia and probable histoplasmosis in a patient infected with HIV. Case report.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Those infected by human immunodeficiency virus (HIV) have a higher risk of opportunistic infections. The risk is related to the level of immunosuppression. We report a case of a young male with the unusual scenario of three opportunistic infections occurring simultaneously:

Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

OBJECTIVE To review the literature on the use of probiotics to treat or prevent recurrences of Clostridium difficile-associated diarrhea (CDAD) by replacing normal gastric flora. METHODS PubMed (1970-March 2007) was searched using the terms probiotics, Clostridium difficile, colitis, diarrhea,

[Saccharomyces cerevisiae fungemia in an elderly patient following probiotic treatment].

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Saccharomyces cerevisiae, known as baker's yeast, is also used as a probiotic agent to treat gastroenteritis by modulating the endogenous flora and immune system. However, since there have been increasing reports of fungemia due to S.cerevisiae and its subspecies S.boulardii, it is recommended that

Fungemia following Saccharomyces cerevisiae var. boulardii probiotic treatment in an elderly patient.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

The yeast Saccharomyces cerevisiae var. boulardii is a biotherapeutic agent used for the prevention and treatment of several gastrointestinal diseases. We report a case of fungemia in a patient suffering from Clostridiumdifficile-associated diarrhea and treated with metronidazole and a probiotic

Seven cases of fungemia with Saccharomyces boulardii in critically ill patients.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Saccharomyces boulardii (Sb) is a particular strain of Saccharomyces cerevisiae (Sc). This viable yeast is used in intensive care adult patients, delivered in packets of 500 mg, for preventing diarrhea associated with antibiotics or enteral feeding at a regimen of 1-2 g/day. Between June 1996 and

[Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities].

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

METHODS A 48-year-old diabetic with multiple co-morbidities presented with generalized micro- and macroangiopathy including peripheral artery disease stage IV with necroses in several digits of both feet. He was admitted to the department of surgery for the insertion of femoropopliteal

Saccharomyces cerevisiae fungemia: an emerging infectious disease.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

BACKGROUND Saccharomyces cerevisiae is well known in the baking and brewing industry and is also used as a probiotic in humans. However, it is a very uncommon cause of infection in humans. METHODS During the period of 15-30 April 2003, we found 3 patients with S. cerevisiae fungemia in an intensive

Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

A case of Saccharomyces fungemia in an 8-month-old baby affected by acute myeloid leukemia while receiving intensive chemotherapy is reported. The patient was receiving prophylaxis treatment with Saccharomyces boulardii capsules (Codex) to prevent diarrhea, which is commonly associated with this

Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Probiotics are commonly prescribed as an adjuvant in the treatment of antibiotic-associated diarrhea caused by Clostridium difficile. We report the case of an immunocompromised 73-year-old patient on chemotherapy who developed Saccharomyces cerevisiae var. boulardii fungemia in a central venous

Trichosporon beigelii causing oral mucositis and fungemia: report of one case.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

A 23-month-old boy, a victim of acute myelomonocytic leukemia (AML), was admitted for chemotherapy. On the eighth hospital day, he started a one-week course of chemotherapy with agents of epirubicin and cytosine arabinoside. Unfortunately, persistent neutropenia, deteriorating diarrhea and

SACCHAROMYCES CEREVISIAE FUNGEMIA IN A PEDIATRIC PATIENT AFTER TREATMENT WITH PROBIOTICS.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

OBJECTIVE To report the case of a one-year-old patient with a bloodstream infection associated with probiotics, and to discuss the indications and precautions concerning the therapeutic use of probiotics. METHODS A one-year-old male patient with Down syndrome in a late postoperative period of

Enteral feeding intolerance: an indicator of sepsis-associated mortality in burned children.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

OBJECTIVE To determine if enteral feeding intolerance (EFI) is associated with sepsis and increased mortality in children with severe burns. METHODS A survey. METHODS A pediatric burn unit. METHODS Ninety-one children surviving longer than 5 days with greater than 80% total body surface area

Saccharomyces: A Friend or Foe in ICU (A Case Report with Solution).

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Saccharomyces cerevisiae or boulardii, also known as baker's yeast or brewer's yeast, is normally a nonpathogenic microbe. It is commonly used as a probiotic to prevent antibiotic-associated diarrhea. We present a case of a 77-year-old woman with uncontrolled diabetes who developed

Fyrri
1
2
Næst

Skráðu þig á
facebook síðu okkar

Herbal & Natural Medicine

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

Virkar á 55 tungumálum
Jurtalækningar studdir af vísindum
Jurtaviðurkenning eftir ímynd
Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
Lestu vísindarit sem tengjast leit þinni
Leitaðu að lækningajurtum eftir áhrifum þeirra
Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum